Additionally, wild-type RTKs sunitinib also exhibited a potent inhibitory capacity against mutated RTKs with constitutive kinase activities, including mutant forms of KIT or PDGFR-a playing a key regulatory role in GIST pathogenesis [32,33]. Here, KIT is linked to gastrointestinal stromal tumor.